Cannabinoids in a Pill? One Company’s Research to Find the Next Cannabinoid-Based Medication
May 10th 2022Dr. Woody, chief executive officer of 180 Life Sciences, discusses in this interview the current research surrounding synthetic cannabinoids as a treatment for chronic pain, as well as the development of a new type of medication that would have the potential to offer the benefits of cannabis without any undesirable effects.